Cargando…

Heterogeneity in cardiovascular death or hospitalization for heart failure benefits with flozins is linked to weight

AIMS: Cardiovascular outcome trials with sodium–glucose cotransporter 2 inhibitors (SGLT‐2is) have documented a positive impact on micro‐ and macrovascular complications of type 2 diabetes (T2D). Most analyses suggest that these benefits are independent of achieving metabolic control. This meta‐regr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghosal, Samit, Sinha, Binayak, Mukherjee, Rik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053285/ https://www.ncbi.nlm.nih.gov/pubmed/36707061 http://dx.doi.org/10.1002/ehf2.14296

Ejemplares similares

LBODP046 Reduction In "Cardiovascular Death Or Hospitalisation For Heart Failure" With Sglt-2is Is Dependent On Weight Reduction: A Meta-regression Analysis
por: Ghosal, Samit, et al.
Publicado: (2022)

Exploring the comparative cardiovascular death benefits of sodium–glucose cotransporter 2 inhibitors in type 2 diabetes: a frequentist and Bayesian network meta-analysis-based scoring
por: Ghosal, Samit, et al.
Publicado: (2023)

Sodium-Glucose Cotransporter-2 Inhibitors (SGLT-2i) Reduce Hospitalization for Heart Failure Only and Have No Effect on Atherosclerotic Cardiovascular Events: A Meta-Analysis
por: Sinha, Binayak, et al.
Publicado: (2019)

The Impact of Pharmacotherapy for Heart Failure on Oxidative Stress—Role of New Drugs, Flozins
por: Bodnar, Patryk, et al.
Publicado: (2023)

Gliptins and Cardiovascular Outcomes: A Comparative and Critical Analysis after TECOS
por: Ghosal, Samit, et al.
Publicado: (2016)

Assessing the need for pioglitazone in the treatment of patients with type 2 diabetes: a meta-analysis of its risks and benefits from prospective trials
por: Sinha, Binayak, et al.
Publicado: (2020)

Rapid sputum testing and not thermal screening alone should be the first-line screening test at airports: A Bayesian analysis
por: Ghosal, Samit, et al.
Publicado: (2020)

A Meta-Analysis of the Effect of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic Parameters in Patients With Polycystic Ovary Syndrome
por: Sinha, Binayak, et al.
Publicado: (2022)

A Target HbA1c Between 7 and 7.7% Reduces Microvascular and Macrovascular Events in T2D Regardless of Duration of Diabetes: a Meta-Analysis of Randomized Controlled Trials
por: Sinha, Binayak, et al.
Publicado: (2021)

Assessing the Effects of Modern Renoprotective Agents in Preventing Progression of Renal Composite Outcomes in Patients with Type 2 Diabetes: A Network Meta-analysis
por: Ghosal, Samit, et al.
Publicado: (2022)

Finerenone in type 2 diabetes and renal outcomes: A random-effects model meta-analysis
por: Ghosal, Samit, et al.
Publicado: (2023)

Quantitative measure of asymptomatic cardiovascular disease risk in Type 2 diabetes: Evidence from Indian outpatient setting
por: Ghosal, Samit, et al.
Publicado: (2020)

Linear Regression Analysis to predict the number of deaths in India due to SARS-CoV-2 at 6 weeks from day 0 (100 cases - March 14th 2020)
por: Ghosal, Samit, et al.
Publicado: (2020)

A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D)
por: Ghosal, Samit, et al.
Publicado: (2021)

Meta‐analysis of the effects of sodium glucose cotransporter 2 inhibitors in non‐alcoholic fatty liver disease patients with type 2 diabetes
por: Sinha, Binayak, et al.
Publicado: (2020)

Is insulin degludec a more effective treatment for patients using high doses of insulin glargine but not attaining euglycemia? Some case reports from India
por: Sinha, Binayak, et al.
Publicado: (2014)

“Compliance of the Indian National Task Force guidelines for COVID-19 recommendation by Indian doctors – A survey"
por: Gangopadhyay, Kalyan Kumar, et al.
Publicado: (2020)

Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysis
por: Ghosal, Samit, et al.
Publicado: (2020)

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors and CKD: Are You a #Flozinator?
por: Krishnan, Anoushka, et al.
Publicado: (2023)

Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis
por: Ghosal, Samit, et al.
Publicado: (2020)

The Renal Composite Benefit of Sodium Glucose Co-Transporter 2 Inhibitors Should Ideally Be Assessed Based on a Standardised Definition: A Meta-Analysis of Randomised Controlled Trials
por: Ghosal, Samit, et al.
Publicado: (2023)

Impact of complete lockdown on total infection and death rates: A hierarchical cluster analysis
por: Ghosal, Samit, et al.
Publicado: (2020)

Extremes of both weight gain and weight loss are associated with increased incidence of heart failure and cardiovascular death: evidence from the CANVAS Program and CREDENCE
por: Ferrannini, Giulia, et al.
Publicado: (2023)

Impact of mitral regurgitation on cardiovascular hospitalization and death in newly diagnosed heart failure patients
por: Cork, David P., et al.
Publicado: (2020)

Cardiovascular vs. non‐cardiovascular deaths after heart failure hospitalization in young, older, and very old patients
por: Nakamaru, Ryo, et al.
Publicado: (2022)

SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: A systematic review and meta-analysis
por: Cardoso, Rhanderson, et al.
Publicado: (2021)

Teneligliptin and “Thorough QTc study”: thorough enough?
por: Ghosal, Samit
Publicado: (2019)

Selecting antihyperglycemic agents with proven safety: A must in COVID-19 era
por: Ghosal, Samit
Publicado: (2020)

Reply to letter to the editor regarding article: Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysis (Ghosal et al.)
por: Ghosal, Samit
Publicado: (2020)

Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death
por: Brady, Paul F., et al.
Publicado: (2022)

An electrocardiography score predicts heart failure hospitalization or death beyond that of cardiovascular magnetic resonance imaging
por: Maanja, Maren, et al.
Publicado: (2022)

Benefit of Heart Rate Reduction in Heart Failure
por: Hasenfuss, Gerd
Publicado: (2010)

Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: rationale and design of the OptiLink HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status Monitoring and CareLink)
por: Brachmann, Johannes, et al.
Publicado: (2011)

Cardiovascular Risks and Benefits of Medications Used for Weight Loss
por: Bramante, Carolyn T., et al.
Publicado: (2020)

Estimating the Lifetime Benefits of Treatments for Heart Failure
por: Ferreira, João Pedro, et al.
Publicado: (2020)

Cardiovascular Benefits of Resistance Training in Patients With Heart Failure With Reduced Ejection Fraction: A Systematic Review
por: Danduboyina, Anirudh, et al.
Publicado: (2023)

Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links?
por: Sinha, Aish, et al.
Publicado: (2023)

The impact of the coronavirus disease and Tele-Heart Failure Clinic on cardiovascular mortality and heart failure hospitalization in ambulatory patients with heart failure
por: Puwanant, Sarinya, et al.
Publicado: (2021)

The heterogeneity in link weights may decrease the robustness of real-world complex weighted networks
por: Bellingeri, M., et al.
Publicado: (2019)

Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community‐Dwelling Population
por: Parikh, Ravi H., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tqpee1lsrlohhrhp5hil1i9vt9